This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory Policy change

US Kidney Transplant Policy Reverses Racial Bias

Analysis based on 10 articles · First reported Mar 09, 2026 · Last updated Mar 09, 2026

Sentiment
40
Attention
2
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The policy change aims to address racial bias in medical testing, potentially leading to improved health outcomes for Black patients. This could have a positive long-term impact on healthcare equity and public trust in medical institutions.

Healthcare Medical research

An effort to reverse the effects of a racially biased medical test that delayed kidney transplants for Black people in the United States is showing positive results. The U.S. transplant system ended the use of a race-based formula for calculating kidney function in 2023 and ordered hospitals to credit Black patients on transplant lists for time lost due to the biased test. A study by researchers at Beth Israel Deaconess Medical Center, Brigham and Women s Hospital, and Boston Medical Center, led by Rohan Khazanchi, found that thousands of Black transplant candidates gained a median of 1.7 years on the waiting list, and their transplant rate increased. The findings suggest that improving transplant care for Black individuals did not negatively impact individuals of other races.

90 United States ended use of race-based kidney function test
90 United States ordered hospitals to credit Black patients with lost waiting time
80 Rohan Khazanchi led the study on policy change impact
70 Beth Israel Deaconess Medical Center analyzed kidney transplant database
70 Brigham and Women s Hospital analyzed kidney transplant database
70 Boston Medical Center analyzed kidney transplant database
per
Rohan Khazanchi led the study on the kidney transplant policy change, expressing hope that the policy helps move towards equity. He highlighted the challenges in implementing wait-time modifications.
Importance 80 Sentiment 30
priv
Beth Israel Deaconess Medical Center was involved in the research that analyzed the impact of the policy change on kidney transplant rates for Black patients. Their findings suggest the policy is working towards equity.
Importance 70 Sentiment 20
priv
Brigham and Women s Hospital participated in the study analyzing the effects of the policy change on kidney transplant rates. Dr. Rohan Khazanchi, who led the study, is affiliated with this institution.
Importance 70 Sentiment 20
priv
Boston Medical Center was part of the research team that studied the impact of the policy change on kidney transplant waiting lists for Black patients. Dr. Rohan Khazanchi, a leader of the study, is associated with this center.
Importance 70 Sentiment 20
cnt
The United States transplant system implemented the policy change to reverse the effects of a racially biased medical test, impacting thousands of Black transplant candidates across the nation.
Importance 60 Sentiment 10
per
L. Ebony Boulware of Wake Forest School of Medicine provided an accompanying commentary on the study, supporting similar efforts to mitigate harm from race-based medical tests.
Importance 20 Sentiment 10
priv
Wake Forest School of Medicine is the institution where Dr. L. Ebony Boulware, who commented on the study, is affiliated.
Importance 20 Sentiment 10
+ 2 more entities View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.